We developed a tandem electrocatalyst for CO 2 -to-CO conversion comprising the single Cu site co-coordinated with N and S anchored carbon matrix (Cu-S 1 N 3 ) and atomically dispersed Cu clusters (Cu x ), denoted as Cu-S 1 N 3 /Cu x . The as-prepared Cu-S 1 N 3 /Cu x composite presents a 100 % Faradaic efficiency towards CO generation (FE CO ) at À0.65 V vs. RHE and high FE CO over 90 % from À0.55 to À0.75 V, outperforming the analogues with Cu-N 4 (FE CO only 54 % at À0.7 V) and Cu-S 1 N 3 (FE CO 70 % at À0.7 V) configurations. The unsymmetrical Cu-S 1 N 3 atomic interface in the carbon basal plane possesses an optimized binding energy for the key intermediate *COOH compared with Cu-N 4 site. At the same time, the adjacent Cu x effectively promotes the protonation of *CO 2 À by accelerating water dissociation and offering *H to the Cu-S 1 N 3 active sites. This work provides a tandem strategy for facilitating proton-coupled electron transfer over the atomic-level catalytic sites.Electrochemical reduction CO 2 to value-added fuels using renewable electricity is one of appealing CO 2 utilization strategies for management of the global carbon balance. [1] Recent technoeconomic analysis shows that the reduction of CO 2 to CO or formic acid through two-electron transfer processes is the most economical approach for CO 2 conversion, owing to their high added value per KJ of electrical energy input. [2] As a typical product, CO, especially with high purity, is very attractive, because it can be readily used as an important feed-stock for a couple of chemical engineering processes such as Fischer-Tropsch synthesis. [3] Thus, efficient CO 2 -to-CO conversion catalysts with adequate activity and selectivity are highly desired.
Capacitive deionization has been considered as a promising solution to the challenge of freshwater shortage due to its high efficiency, low environmental footprint, and low energy consumption. However, developing advanced electrode materials to improve capacitive deionization performance remains a challenge. Herein, the hierarchical bismuthene nanosheets (Bi-ene NSs)@MXene heterostructure was successfully prepared by combining the Lewis acidic molten salt etching and the galvanic replacement reaction, which achieves the effective utilization of the molten salt etching byproducts (residual copper). The vertically aligned bismuthene nanosheets array evenly in situ grown on the surface of MXene, which not only facilitate ion and electron transport as well as offer abundant active sites but also provide strong interfacial interaction between bismuthene and MXene. Benefiting from the above advantages, the Bi-ene NSs@MXene heterostructure as a promising capacitive deionization electrode material exhibits high desalination capacity (88.2 mg/g at 1.2 V), fast desalination rate, and good long-term cycling performance. Moreover, the mechanisms involved were elaborated by systematical characterizations and density functional theory calculations. This work provides inspirations for the preparation of MXene-based heterostructures and their application for capacitive deionization.
Antigen 85B (Ag85B) is an important immunodominant antigen of Mycobacterium tuberculosis, and is a very promising vaccine candidate molecule. Rv3425 is a member of the subgroup 3 of the PPE family, which does not exist in all BCG strains. In this study we constructed a new rBCG which included this united gene (Ag85B-Rv3425). The level of antigen-stimulated T cells expressing IFN-gamma was significantly higher in the C57BL/6 mice vaccinated with rBCG::Ag85B-Rv3425 than with BCG. In addition, the sera from mice immunized with rBCG::Ag85B-Rv3425 revealed an increase in the specific immunoglobulin G titers than that from mice immunized with BCG. Antigen specific IgG subclass analysis showed that rBCG::Ag85B-Rv3425 tended to facilitate IgG2a production, suggesting enhancement of predominant Th1 response which in turn may facilitate increased production of protective IFN-gamma. These results suggested that this rBCG::Ag85B-Rv3425 could be a strong vaccine candidate for further study.
Zfp462 is a newly identified vertebrate-specific zinc finger protein that contains nearly 2500 amino acids and 23 putative C2H2-type zinc finger domains. So far, the functions of Zfp462 remain unclear. In our study, we showed that Zfp462 is expressed predominantly in the developing brain, especially in the cerebral cortex and hippocampus regions from embryonic day 7.5 to early postnatal stage. By using a piggyBac transposon-generated Zfp462 knockout (KO) mouse model, we found that Zfp462 KO mice exhibited prenatal lethality with normal neural tube patterning, whereas heterozygous (Het) Zfp462 KO (Zfp462 ) mice showed developmental delay with low body weight and brain weight. Behavioral studies showed that Zfp462 mice presented anxiety-like behaviors with excessive self-grooming and hair loss, which were similar to the pathological grooming behaviors in Hoxb8 KO mice. Further analysis of grooming microstructure showed the impairment of grooming patterning in Zfp462 mice. In addition, the mRNA levels of Pbx1 (pre-B-cell leukemia homeobox 1, an interacting protein of Zfp462) and Hoxb8 decreased in the brains of Zfp462 mice, which may be the cause of anxiety-like behaviors. Finally, imipramine, a widely used and effective anti-anxiety medicine, rescued anxiety-like behaviors and excessive self-grooming in Zfp462 mice. In conclusion, Zfp462 deficiency causes anxiety-like behaviors with excessive self-grooming in mice. This provides a novel genetic mouse model for anxiety disorders and a useful tool to determine potential therapeutic targets for anxiety disorders and screen anti-anxiety drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.